1.
Clin Pract Cases Emerg Med
; 7(3): 168-171, 2023 Aug.
Article
in English
| MEDLINE
| ID: mdl-37595307
ABSTRACT
INTRODUCTION: Tissue plasminogen activator (tPA), commonly used for treatment of acute ischemic stroke, is associated with life-threatening bleeding intracranially as well as surrounding the airway. CASE REPORT: A 78-year-old year old male who presented with stroke symptoms and after tPA administration developed a retropharyngeal hematoma requiring intubation and surgical intervention. CONCLUSION: Numerous threats to the patient's airway can develop after tPA administration. While angioedema is the most common cause, it is important to be prepared for other causes related to hemorrhage.